Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000817276 | SCV000957826 | pathogenic | Pulmonary hypertension, primary, 1 | 2018-09-06 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exons 4-7 of the BMPR2 gene. It preserves the integrity of the reading frame. Similar deletions of exons 4-7 has been observed in individuals affected with pulmonary arterial hypertension (PMID: 26387786, Invitae). Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV001388556 | SCV001589575 | pathogenic | Primary pulmonary hypertension | 2018-08-30 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exons 4-7 of the BMPR2 gene. It preserves the integrity of the reading frame. Similar deletions of exons 4-7 has been observed in individuals affected with pulmonary arterial hypertension (PMID: 26387786, Invitae). Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. For these reasons, this variant has been classified as Pathogenic. |